Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin
- PMID: 21088396
- DOI: 10.1159/000320943
Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin
Abstract
Background: Due to its increased non-susceptibility rates, Klebsiella pneumoniae has emerged as one of the most problematic pathogens.
Methods: The level of resistance to 25 antimicrobials of K. pneumoniae isolates from a teaching hospital in Greece and the evolution trends during 2 decades were examined.
Results: A statistically significant increase in non-susceptibility rates was found for almost all antimicrobials examined. During 2008, the isolates presented non-susceptibility rates to aminoglycosides >50% and to quinolones >60%. Nowadays, 1 out of 10 isolates is non-susceptible to colistin. Moreover, the isolates non-susceptible to imipenem were almost doubled between 2007 (29%) and 2008 (50%). Among the imipenem-resistant isolates, 1 out of 4 was also resistant to colistin.
Conclusion: The effectiveness of carbapenems has been compromised and the increase in resistance to colistin is rapid and steep.
Copyright © 2010 S. Karger AG, Basel.
Similar articles
-
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.J Hosp Infect. 2010 Sep;76(1):70-3. doi: 10.1016/j.jhin.2010.03.021. Epub 2010 Jun 17. J Hosp Infect. 2010. PMID: 20705205
-
Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.J Antimicrob Chemother. 2008 Jan;61(1):59-63. doi: 10.1093/jac/dkm443. Epub 2007 Nov 13. J Antimicrob Chemother. 2008. PMID: 17999975
-
Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011.Euro Surveill. 2012 Aug 16;17(33):20248. Euro Surveill. 2012. PMID: 22913977
-
Colistin resistance in Klebsiella pneumoniae.Int J Antimicrob Agents. 2014 Jul;44(1):8-15. doi: 10.1016/j.ijantimicag.2014.02.016. Epub 2014 Apr 12. Int J Antimicrob Agents. 2014. PMID: 24794735 Review.
-
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.Expert Rev Anti Infect Ther. 2013 Feb;11(2):159-77. doi: 10.1586/eri.12.162. Expert Rev Anti Infect Ther. 2013. PMID: 23409822 Review.
Cited by
-
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.Antimicrob Agents Chemother. 2013 Mar;57(3):1394-403. doi: 10.1128/AAC.02058-12. Epub 2013 Jan 7. Antimicrob Agents Chemother. 2013. PMID: 23295920 Free PMC article.
-
Development and Multicentric Validation of a Lateral Flow Immunoassay for Rapid Detection of MCR-1-Producing Enterobacteriaceae.J Clin Microbiol. 2019 Apr 26;57(5):e01454-18. doi: 10.1128/JCM.01454-18. Print 2019 May. J Clin Microbiol. 2019. PMID: 30842227 Free PMC article.
-
Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.J Antimicrob Chemother. 2020 Jan 1;75(1):110-116. doi: 10.1093/jac/dkz405. J Antimicrob Chemother. 2020. PMID: 31580426 Free PMC article.
-
Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae.Sci Rep. 2021 Jan 8;11(1):18. doi: 10.1038/s41598-020-78098-4. Sci Rep. 2021. PMID: 33420122 Free PMC article.
-
Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.Clin Microbiol Rev. 2012 Oct;25(4):682-707. doi: 10.1128/CMR.05035-11. Clin Microbiol Rev. 2012. PMID: 23034326 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical